Business Context and Reporting Period
Company: Biorestorative Therapies, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: September 25, 2012
Event: Appointment of Dr. Wayne Marasco as Chairman of the Company's Scientific Advisory Board.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document is a current report regarding a corporate governance event.
Material Changes
The filing reports a change in the composition of the Scientific Advisory Board with the appointment of Dr. Wayne Marasco as Chairman. No financial or operational changes are detailed in this report.
Guidance, Outlook, and Risks
The filing explicitly states that the information is furnished, not filed, and will not be incorporated by reference into registration statements unless specifically identified. The Company notes that the furnishing of this information does not constitute a determination that the information is material or complete, nor is it intended to influence investment decisions. No financial guidance, outlook, or specific risk factors are provided in this text.
Investor Verification Checklist
- Verify the full text of the Press Release (Exhibit 99.1) for details on Dr. Marasco's background and the scope of his role.
- Confirm the current status of the Scientific Advisory Board and any other recent appointments.
- Review the Company's most recent 10-K or 10-Q filings for actual financial performance and liquidity status, as this 8-K contains no such data.